Female Reproductive System Neoplasm — Trials

Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,170 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 489 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02208375	mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian	active not recruiting	Phase 1	159	M.D. Anderson Cancer CenterOTHER	1	Sep 4, 2026	clinicaltrials
NCT04704661	Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial	active not recruiting	Phase 1	51	National Cancer Institute (NCI)NIH	1	Sep 4, 2026